ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3034% above fair value
$179.27+1.97 (+1.11%)
Close on Nov 13, 2026Market cap $4.48BP/E 74.4Yield –
ICU Medical cash
Cash and short-term investments held at the end of each period.
ICU Medical's cash was $301.78M at Sep 30, 2026. For fiscal 2025 it was $307.96M, down 0.2% from the year before. Over ten years it grew -2.0% a year on average. The highest annual figure on record is $567.25M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $307.96M | -0.2% |
| FY2024 | Dec 31, 2024 | $308.57M | +21.1% |
| FY2023 | Dec 31, 2023 | $254.72M | +19.6% |
| FY2022 | Dec 31, 2022 | $213.01M | -62.4% |
| FY2021 | Dec 31, 2021 | $567.25M | +38.1% |
| FY2020 | Dec 31, 2020 | $410.78M | +40.4% |
| FY2019 | Dec 31, 2019 | $292.64M | -23.4% |
| FY2018 | Dec 31, 2018 | $382.11M | +27.3% |
| FY2017 | Dec 31, 2017 | $300.13M | -32.6% |
| FY2016 | Dec 31, 2016 | $445.08M | +17.9% |
| FY2015 | Dec 31, 2015 | $377.40M | +8.8% |
| FY2014 | Dec 31, 2014 | $346.76M | +16.8% |
| FY2013 | Dec 31, 2013 | $296.89M | +31.3% |
| FY2012 | Dec 31, 2012 | $226.16M | +41.4% |
| FY2011 | Dec 31, 2011 | $159.99M | +71.4% |
| FY2010 | Dec 31, 2010 | $93.36M | -13.7% |
| FY2009 | Dec 31, 2009 | $108.14M | -3.3% |
| FY2008 | Dec 31, 2008 | $111.79M | +1319.9% |
| FY2007 | Dec 31, 2007 | $7.87M | -40.1% |
| FY2006 | Dec 31, 2006 | $13.15M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $301.78M | +0.7% |
| Q2 FY2026 | Jun 30, 2026 | $298.30M | -0.6% |
| Q1 FY2026 | Mar 31, 2026 | $288.33M | -0.5% |
| Q4 FY2025 | Dec 31, 2025 | $307.96M | -0.2% |
| Q3 FY2025 | Sep 30, 2025 | $299.73M | -4.1% |
| Q2 FY2025 | Jun 30, 2025 | $300.03M | -0.9% |
| Q1 FY2025 | Mar 31, 2025 | $289.70M | +15.2% |
| Q4 FY2024 | Dec 31, 2024 | $308.57M | +21.1% |
| Q3 FY2024 | Sep 30, 2024 | $312.51M | +57.0% |
| Q2 FY2024 | Jun 30, 2024 | $302.65M | +53.1% |
| Q1 FY2024 | Mar 31, 2024 | $251.42M | +12.2% |
| Q4 FY2023 | Dec 31, 2023 | $254.72M | +19.6% |
| Q3 FY2023 | Sep 30, 2023 | $199.00M | -19.4% |
| Q2 FY2023 | Jun 30, 2023 | $197.70M | -26.5% |
| Q1 FY2023 | Mar 31, 2023 | $224.18M | -34.9% |
| Q4 FY2022 | Dec 31, 2022 | $213.01M | -62.4% |
| Q3 FY2022 | Sep 30, 2022 | $246.80M | -54.1% |
| Q2 FY2022 | Jun 30, 2022 | $268.89M | -43.6% |
| Q1 FY2022 | Mar 31, 2022 | $344.29M | -21.0% |
| Q4 FY2021 | Dec 31, 2021 | $567.25M | +38.1% |
| Q3 FY2021 | Sep 30, 2021 | $537.49M | +47.9% |
| Q2 FY2021 | Jun 30, 2021 | $476.70M | +3.5% |
| Q1 FY2021 | Mar 31, 2021 | $435.94M | -0.8% |
| Q4 FY2020 | Dec 31, 2020 | $410.78M | +40.4% |
| Q3 FY2020 | Sep 30, 2020 | $363.54M | +7.9% |
| Q2 FY2020 | Jun 30, 2020 | $460.70M | +46.8% |
| Q1 FY2020 | Mar 31, 2020 | $439.67M | +40.4% |
| Q4 FY2019 | Dec 31, 2019 | $292.64M | -23.4% |
| Q3 FY2019 | Sep 30, 2019 | $336.79M | -5.3% |
| Q2 FY2019 | Jun 30, 2019 | $313.73M | -4.1% |
| Q1 FY2019 | Mar 31, 2019 | $313.26M | +16.6% |
| Q4 FY2018 | Dec 31, 2018 | $382.11M | +27.3% |
| Q3 FY2018 | Sep 30, 2018 | $355.78M | +14.7% |
| Q2 FY2018 | Jun 30, 2018 | $327.17M | +35.8% |
| Q1 FY2018 | Mar 31, 2018 | $268.72M | +33.1% |
| Q4 FY2017 | Dec 31, 2017 | $300.13M | -32.6% |
| Q3 FY2017 | Sep 30, 2017 | $310.21M | – |
| Q2 FY2017 | Jun 30, 2017 | $240.92M | – |
| Q1 FY2017 | Mar 31, 2017 | $201.86M | – |
| Q4 FY2016 | Dec 31, 2016 | $445.08M | – |
See a number that looks wrong?